25 XP   0   0   10

ENDRA Life Sciences Inc
Buy, Hold or Sell?

Let's analyse ENDRA Life Sciences Inc together

PenkeI guess you are interested in ENDRA Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ENDRA Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ENDRA Life Sciences Inc

I send you an email if I find something interesting about ENDRA Life Sciences Inc.

Quick analysis of ENDRA Life Sciences Inc (30 sec.)










What can you expect buying and holding a share of ENDRA Life Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
34.3%

What is your share worth?

Current worth
$0.51
Expected worth in 1 year
$0.37
How sure are you?
31.4%

+ What do you gain per year?

Total Gains per Share
$-0.14
Return On Investment
-57.7%

For what price can you sell your share?

Current Price per Share
$0.24
Expected price per share
$0.221 - $0.9101
How sure are you?
50%

1. Valuation of ENDRA Life Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.24

Intrinsic Value Per Share

$-7.85 - $-9.01

Total Value Per Share

$-7.33 - $-8.49

2. Growth of ENDRA Life Sciences Inc (5 min.)




Is ENDRA Life Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$5.6m$9.9m-$4.3m-78.6%

How much money is ENDRA Life Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m-$714.5b$714.5b28,401,198.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of ENDRA Life Sciences Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#117 / 145

Most Revenue
#145 / 145

Most Profit
#84 / 145

What can you expect buying and holding a share of ENDRA Life Sciences Inc? (5 min.)

Welcome investor! ENDRA Life Sciences Inc's management wants to use your money to grow the business. In return you get a share of ENDRA Life Sciences Inc.

What can you expect buying and holding a share of ENDRA Life Sciences Inc?

First you should know what it really means to hold a share of ENDRA Life Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of ENDRA Life Sciences Inc is $0.2425. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ENDRA Life Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ENDRA Life Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.51. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ENDRA Life Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-54.5%-0.23-94.0%-0.30-123.1%-0.29-120.0%-0.24-99.9%
Usd Book Value Change Per Share0.0417.3%-0.04-14.4%-0.08-33.4%0.00-1.1%0.016.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.0210.0%0.015.7%
Usd Total Gains Per Share0.0417.3%-0.03-14.4%-0.08-33.4%0.028.9%0.0311.7%
Usd Price Per Share2.12-1.73-1.25-1.42-1.43-
Price to Earnings Ratio-4.01--2.16--1.05--1.41--1.67-
Price-to-Total Gains Ratio50.56-10.13--4.50--2.31--6.74-
Price to Book Ratio4.13-3.58-1.81-3.60-1.32-
Price-to-Total Gains Ratio50.56-10.13--4.50--2.31--6.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2425
Number of shares4123
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.040.00
Usd Total Gains Per Share-0.030.02
Gains per Quarter (4123 shares)-144.1388.71
Gains per Year (4123 shares)-576.52354.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-577-587399-44345
22-1155-1164798-88700
33-1732-17411197-1321055
44-2310-23181595-1761410
54-2887-28951994-2201765
65-3464-34722393-2642120
76-4042-40492792-3082475
87-4619-46263191-3522830
98-5197-52033590-3963185
109-5774-57803989-4403540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.035.00.00.0%0.035.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%11.022.02.031.4%11.022.02.031.4%
Dividend per Share1.00.03.025.0%7.00.05.058.3%12.00.08.060.0%12.00.023.034.3%12.00.023.034.3%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%11.022.02.031.4%11.022.02.031.4%

Fundamentals of ENDRA Life Sciences Inc

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Fundamental data was last updated by Penke on 2024-04-11 15:41:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ENDRA Life Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ENDRA Life Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-3,223.9%+3,223.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.7%+6.7%
TTM--6.7%+6.7%
YOY-0.3%-0.3%
5Y--1.5%+1.5%
10Y-3,223.9%-3.4%-3,220.5%
1.1.2. Return on Assets

Shows how efficient ENDRA Life Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • -21.6% Return on Assets means that ENDRA Life Sciences Inc generated $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ENDRA Life Sciences Inc:

  • The MRQ is -21.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.6%TTM-33.6%+12.0%
TTM-33.6%YOY-6,533,537.5%+6,533,503.9%
TTM-33.6%5Y-1,306,745.7%+1,306,712.1%
5Y-1,306,745.7%10Y-746,760.8%-559,984.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.6%-1.3%-20.3%
TTM-33.6%-1.3%-32.3%
YOY-6,533,537.5%-0.9%-6,533,536.6%
5Y-1,306,745.7%-0.5%-1,306,745.2%
10Y-746,760.8%-0.9%-746,759.9%
1.1.3. Return on Equity

Shows how efficient ENDRA Life Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • -25.8% Return on Equity means ENDRA Life Sciences Inc generated $-0.26 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ENDRA Life Sciences Inc:

  • The MRQ is -25.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -47.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.8%TTM-47.0%+21.2%
TTM-47.0%YOY-7,879,389.4%+7,879,342.5%
TTM-47.0%5Y-1,575,946.5%+1,575,899.6%
5Y-1,575,946.5%10Y-900,588.4%-675,358.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.8%-0.5%-25.3%
TTM-47.0%--47.0%
YOY-7,879,389.4%0.3%-7,879,389.7%
5Y-1,575,946.5%-1.4%-1,575,945.1%
10Y-900,588.4%-2.3%-900,586.1%

1.2. Operating Efficiency of ENDRA Life Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ENDRA Life Sciences Inc is operating .

  • Measures how much profit ENDRA Life Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-3,193.7%+3,193.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM-0.5%-0.5%
YOY-4.0%-4.0%
5Y-3.7%-3.7%
10Y-3,193.7%-1.3%-3,192.4%
1.2.2. Operating Ratio

Measures how efficient ENDRA Life Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y53.657-53.657
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.280-1.280
TTM-1.304-1.304
YOY-1.236-1.236
5Y-1.242-1.242
10Y53.6571.205+52.452

1.3. Liquidity of ENDRA Life Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ENDRA Life Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.36 means the company has $3.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ENDRA Life Sciences Inc:

  • The MRQ is 3.358. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.324. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.358TTM3.324+0.034
TTM3.324YOY7.220-3.896
TTM3.3245Y6.065-2.741
5Y6.06510Y6.252-0.187
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3582.111+1.247
TTM3.3242.298+1.026
YOY7.2202.599+4.621
5Y6.0653.012+3.053
10Y6.2523.081+3.171
1.3.2. Quick Ratio

Measures if ENDRA Life Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.23 means the company can pay off $0.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.234. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.357. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.234TTM1.357-1.123
TTM1.357YOY5.082-3.725
TTM1.3575Y4.855-3.499
5Y4.85510Y5.342-0.487
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2341.204-0.970
TTM1.3571.319+0.038
YOY5.0821.602+3.480
5Y4.8551.943+2.912
10Y5.3422.203+3.139

1.4. Solvency of ENDRA Life Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ENDRA Life Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ENDRA Life Sciences Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.16 means that ENDRA Life Sciences Inc assets are financed with 16.2% credit (debt) and the remaining percentage (100% - 16.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.162. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.263. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.162TTM0.263-0.101
TTM0.263YOY0.174+0.089
TTM0.2635Y0.272-0.009
5Y0.27210Y0.501-0.229
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1620.429-0.267
TTM0.2630.407-0.144
YOY0.1740.394-0.220
5Y0.2720.450-0.178
10Y0.5010.450+0.051
1.4.2. Debt to Equity Ratio

Measures if ENDRA Life Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 19.4% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ENDRA Life Sciences Inc:

  • The MRQ is 0.194. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.367. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.194TTM0.367-0.174
TTM0.367YOY0.213+0.155
TTM0.3675Y0.472-0.105
5Y0.47210Y0.432+0.040
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1940.606-0.412
TTM0.3670.571-0.204
YOY0.2130.631-0.418
5Y0.4720.658-0.186
10Y0.4320.735-0.303

2. Market Valuation of ENDRA Life Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ENDRA Life Sciences Inc generates.

  • Above 15 is considered overpriced but always compare ENDRA Life Sciences Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -4.01 means the investor is paying $-4.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ENDRA Life Sciences Inc:

  • The EOD is -0.458. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.007. Based on the earnings, the company is expensive. -2
  • The TTM is -2.162. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.458MRQ-4.007+3.549
MRQ-4.007TTM-2.162-1.845
TTM-2.162YOY-1.054-1.109
TTM-2.1625Y-1.410-0.752
5Y-1.41010Y-1.673+0.263
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.458-0.235-0.223
MRQ-4.007-0.395-3.612
TTM-2.162-0.284-1.878
YOY-1.0540.002-1.056
5Y-1.4104.834-6.244
10Y-1.6735.200-6.873
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ENDRA Life Sciences Inc:

  • The EOD is -0.307. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.681. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.014. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.307MRQ-2.681+2.375
MRQ-2.681TTM-2.014-0.667
TTM-2.014YOY-1.094-0.920
TTM-2.0145Y-1.549-0.465
5Y-1.54910Y-2.293+0.744
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.307-0.277-0.030
MRQ-2.681-0.441-2.240
TTM-2.014-1.389-0.625
YOY-1.094-2.030+0.936
5Y-1.549-1.446-0.103
10Y-2.293-1.971-0.322
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ENDRA Life Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 4.13 means the investor is paying $4.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of ENDRA Life Sciences Inc:

  • The EOD is 0.473. Based on the equity, the company is cheap. +2
  • The MRQ is 4.134. Based on the equity, the company is fair priced.
  • The TTM is 3.584. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.473MRQ4.134-3.661
MRQ4.134TTM3.584+0.550
TTM3.584YOY1.808+1.776
TTM3.5845Y3.597-0.013
5Y3.59710Y1.315+2.282
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.4731.897-1.424
MRQ4.1342.222+1.912
TTM3.5842.168+1.416
YOY1.8083.041-1.233
5Y3.5973.477+0.120
10Y1.3154.125-2.810
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ENDRA Life Sciences Inc.

3.1. Institutions holding ENDRA Life Sciences Inc

Institutions are holding 1.551% of the shares of ENDRA Life Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Geode Capital Management, LLC0.472905218328165.7042
2023-12-31Vanguard Group Inc0.36080398128732.242
2023-12-31Goss Wealth Management LLC0.28320.000631257-808-2.5199
2023-12-31JPMorgan Chase & Co0.0292032272439309.5178
2023-12-31Tower Research Capital LLC0.0270.00012983-4444-59.8357
2023-12-31Valley National Advisers Inc0.00790.000286900
2023-12-31Morgan Stanley - Brokerage Accounts0.0030332-449-57.4904
2023-12-31Northwestern Mutual Wealth Management Co0.00303293290
2023-12-31BlackRock Inc0.0009010300
2023-12-31Wells Fargo & Co0.000505835.4545
2023-12-31FMR Inc00110
2023-09-30Citadel Advisors Llc000-36701-100
2023-12-31Renaissance Technologies Corp000-10323-100
2023-09-30TWO SIGMA SECURITIES, LLC000-11343-100
2023-09-30HRT FINANCIAL LLC000-10495-100
Total 1.18840.0009131154-68102-51.9%

3.2. Funds holding ENDRA Life Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.360803981200
2024-02-29Fidelity Extended Market Index0.3590.000139616-192-0.4823
2024-02-29Fidelity Series Total Market Index0.08640953000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06730.000374235990418.0042
2023-12-31Northern Trust Extended Eq Market Idx0.06730.000374235990418.0042
2024-02-29Fidelity Total Market Index0.01740192400
2024-02-29Fidelity Nasdaq Composite Index0.01610177300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.01470.0001162700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01180.0001130720.1533
2024-02-29Spartan Total Market Index Pool E0.008088100
2023-12-31SSgA U.S. Extended Market Index Class I0.00660.000172400
2024-03-31State St US Extended Mkt Indx NL Cl C0.0066072400
2024-02-29Spartan Extended Market Index Pool E0.0039043419279.3388
2023-12-31SSgA U.S. Total Market Index Strategy0.00190209-5-2.3364
2023-09-30BlackRock Extended Mkt Composite0.0009010300
2023-12-31Northern Trust Wilshire 50000.000909500
2023-12-31NT US Market Cap Idx Fd - L0.000909500
2024-02-29Fidelity U.S. Equity Index Ins Trust0.0008084840
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00050.00015300
Total 1.03180.0011113837+12061+10.6%

3.3. Insider Transactions

Insiders are holding 4.117% of the shares of ENDRA Life Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-18Michael Milos ThorntonBUY150001.65
2023-05-02Anthony DigiandomenicoBUY833331.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of ENDRA Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.042-0.035+184%-0.081+293%-0.003+106%0.015+186%
Book Value Per Share--0.5130.505+2%0.902-43%0.655-22%0.452+14%
Current Ratio--3.3583.324+1%7.220-53%6.065-45%6.252-46%
Debt To Asset Ratio--0.1620.263-38%0.174-7%0.272-40%0.501-68%
Debt To Equity Ratio--0.1940.367-47%0.213-9%0.472-59%0.432-55%
Dividend Per Share---0.000-100%0.000-100%0.024-100%0.014-100%
Eps---0.132-0.228+72%-0.299+126%-0.291+120%-0.242+83%
Free Cash Flow Per Share---0.198-0.217+10%-0.294+49%-0.241+22%-0.175-11%
Free Cash Flow To Equity Per Share---0.046-0.047+1%-0.104+124%0.053-187%0.117-140%
Gross Profit Margin--1.1011.085+2%1.079+2%1.068+3%1.047+5%
Intrinsic Value_10Y_max---9.007--------
Intrinsic Value_10Y_min---7.847--------
Intrinsic Value_1Y_max---1.003--------
Intrinsic Value_1Y_min---0.985--------
Intrinsic Value_3Y_max---2.937--------
Intrinsic Value_3Y_min---2.806--------
Intrinsic Value_5Y_max---4.779--------
Intrinsic Value_5Y_min---4.443--------
Market Cap2676157.250-774%23395684.00019091761.000+23%13792417.860+70%15669093.824+49%15780231.205+48%
Net Profit Margin----0%-0%-0%-32.2390%
Operating Margin----0%-0%-0%-31.9370%
Operating Ratio----0%-0%-0%53.657-100%
Pb Ratio0.473-774%4.1343.584+15%1.808+129%3.597+15%1.315+214%
Pe Ratio-0.458+89%-4.007-2.162-46%-1.054-74%-1.410-65%-1.673-58%
Price Per Share0.243-774%2.1201.730+23%1.250+70%1.420+49%1.430+48%
Price To Free Cash Flow Ratio-0.307+89%-2.681-2.014-25%-1.094-59%-1.549-42%-2.293-14%
Price To Total Gains Ratio5.784-774%50.56410.126+399%-4.496+109%-2.310+105%-6.739+113%
Quick Ratio--0.2341.357-83%5.082-95%4.855-95%5.342-96%
Return On Assets---0.216-0.336+55%-65335.375+30234486%-13067.457+6046994%-7467.608+3455609%
Return On Equity---0.258-0.470+82%-78793.894+30550279%-15759.465+6110242%-9005.884+3491708%
Total Gains Per Share--0.042-0.035+183%-0.081+293%0.022+95%0.028+47%
Usd Book Value--5658989.0005571221.750+2%9952710.750-43%7233539.950-22%4983638.286+14%
Usd Book Value Change Per Share--0.042-0.035+184%-0.081+293%-0.003+106%0.015+186%
Usd Book Value Per Share--0.5130.505+2%0.902-43%0.655-22%0.452+14%
Usd Dividend Per Share---0.000-100%0.000-100%0.024-100%0.014-100%
Usd Eps---0.132-0.228+72%-0.299+126%-0.291+120%-0.242+83%
Usd Free Cash Flow---2181462.000-2395664.750+10%-3242987.000+49%-2660005.050+22%-1931016.400-11%
Usd Free Cash Flow Per Share---0.198-0.217+10%-0.294+49%-0.241+22%-0.175-11%
Usd Free Cash Flow To Equity Per Share---0.046-0.047+1%-0.104+124%0.053-187%0.117-140%
Usd Market Cap2676157.250-774%23395684.00019091761.000+23%13792417.860+70%15669093.824+49%15780231.205+48%
Usd Price Per Share0.243-774%2.1201.730+23%1.250+70%1.420+49%1.430+48%
Usd Profit---1459536.000-2515917.000+72%-714553085605.750+48957451%-142912933440.300+9791569%-81665137085.571+5595181%
Usd Revenue----0%-0%-0%57703.886-100%
Usd Total Gains Per Share--0.042-0.035+183%-0.081+293%0.022+95%0.028+47%
 EOD+2 -6MRQTTM+27 -5YOY+23 -95Y+21 -1110Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of ENDRA Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.458
Price to Book Ratio (EOD)Between0-10.473
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.234
Current Ratio (MRQ)Greater than13.358
Debt to Asset Ratio (MRQ)Less than10.162
Debt to Equity Ratio (MRQ)Less than10.194
Return on Equity (MRQ)Greater than0.15-0.258
Return on Assets (MRQ)Greater than0.05-0.216
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of ENDRA Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.985
Ma 20Greater thanMa 500.325
Ma 50Greater thanMa 1000.778
Ma 100Greater thanMa 2001.073
OpenGreater thanClose0.254
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,754
Total Liabilities1,095
Total Stockholder Equity5,659
 As reported
Total Liabilities 1,095
Total Stockholder Equity+ 5,659
Total Assets = 6,754

Assets

Total Assets6,754
Total Current Assets3,033
Long-term Assets3,721
Total Current Assets
Cash And Cash Equivalents 2,834
Net Receivables -2,623
Inventory 2,623
Other Current Assets 199
Total Current Assets  (as reported)3,033
Total Current Assets  (calculated)3,033
+/-0
Long-term Assets
Property Plant Equipment 466
Long-term Assets Other 3,255
Long-term Assets  (as reported)3,721
Long-term Assets  (calculated)3,721
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities903
Long-term Liabilities192
Total Stockholder Equity5,659
Total Current Liabilities
Short-term Debt 202
Short Long Term Debt 28
Accounts payable 360
Other Current Liabilities 340
Total Current Liabilities  (as reported)903
Total Current Liabilities  (calculated)932
+/- 28
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt164
Long-term Liabilities  (as reported)192
Long-term Liabilities  (calculated)164
+/- 28
Total Stockholder Equity
Common Stock1
Retained Earnings -91,930
Accumulated Other Comprehensive Income 5
Other Stockholders Equity 97,583
Total Stockholder Equity (as reported)5,659
Total Stockholder Equity (calculated)5,659
+/- 0
Other
Capital Stock1
Cash and Short Term Investments 2,834
Common Stock Shares Outstanding 10,390
Liabilities and Stockholders Equity 6,754
Net Debt -2,440
Net Invested Capital 5,687
Net Working Capital 2,130
Property Plant and Equipment Gross 1,066
Short Long Term Debt Total 394



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
> Total Assets 
473
0
487
0
780
674
491
545
7,945
7,480
6,124
3,690
3,046
1,292
7,223
4,637
3,191
3,615
7,176
4,399
2,863
5,361
8,765
18,899
17,243
15,314
12,875
10,937
15,309
12,343
9,274
6,655
9,245
7,603
6,754
6,7547,6039,2456,6559,27412,34315,30910,93712,87515,31417,24318,8998,7655,3612,8634,3997,1763,6153,1914,6377,2231,2923,0463,6906,1247,4807,94554549167478004870473
   > Total Current Assets 
404
0
127
0
530
362
196
266
7,673
7,223
5,882
3,464
2,834
999
6,950
4,378
2,952
2,976
6,535
3,773
2,275
4,780
8,214
18,351
16,343
14,470
12,094
10,119
14,488
11,565
8,527
5,519
8,084
6,398
3,033
3,0336,3988,0845,5198,52711,56514,48810,11912,09414,47016,34318,3518,2144,7802,2753,7736,5352,9762,9524,3786,9509992,8343,4645,8827,2237,67326619636253001270404
       Cash And Cash Equivalents 
156
0
19
0
500
76
145
134
7,524
6,977
5,602
3,150
2,206
637
6,471
3,925
2,268
2,275
6,174
3,103
749
3,793
7,227
16,843
14,043
11,793
9,462
7,127
11,278
8,016
4,889
2,355
4,819
3,335
2,834
2,8343,3354,8192,3554,8898,01611,2787,1279,46211,79314,04316,8437,2273,7937493,1036,1742,2752,2683,9256,4716372,2063,1505,6026,9777,524134145765000190156
       Net Receivables 
0
0
0
0
0
0
0
76
4
101
7
12
12
12
145
105
244
207
117
373
1,064
562
391
776
969
0
0
0
0
0
0
0
0
0
-2,623
-2,6230000000009697763915621,06437311720724410514512121271014760000000
       Inventory 
239
0
99
0
20
277
40
40
133
132
192
246
279
328
59
74
74
128
113
175
341
323
590
727
1,325
1,500
1,285
1,930
2,375
2,634
2,645
2,735
2,758
2,758
2,623
2,6232,7582,7582,7352,6452,6342,3751,9301,2851,5001,3257275903233411751131287474593282792461921321334040277200990239
       Other Current Assets 
9
0
8
0
10
10
11
16
11
12
14
18
19
21
273
273
366
366
131
122
122
101
6
6
6
1,177
1,348
1,061
835
914
993
429
507
306
199
1993065074299939148351,0611,3481,177666101122122131366366273273211918141211161110100809
   > Long-term Assets 
0
0
360
0
250
311
295
279
272
257
242
226
211
293
273
259
239
639
641
626
587
602
551
547
900
844
781
818
822
778
747
1,136
1,161
1,205
3,721
3,7211,2051,1611,136747778822818781844900547551602587626641639239259273293211226242257272279295311250036000
       Property Plant Equipment 
308
0
360
0
250
311
295
279
272
257
242
226
211
293
273
259
239
639
641
626
587
602
551
547
900
838
775
812
816
772
741
697
625
554
466
46655462569774177281681277583890054755160258762664163923925927329321122624225727227929531125003600308
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-20
0
0
0
6
6
6
6
0
6
0
0
0
0
0000606666000-20000000000000000000000
> Total Liabilities 
111
0
236
0
520
915
1,385
1,925
162
312
848
860
1,105
1,750
975
835
1,366
2,213
2,416
1,877
1,886
2,026
1,596
1,047
2,253
2,158
2,090
1,868
1,975
2,139
2,070
2,156
2,314
2,407
1,095
1,0952,4072,3142,1562,0702,1391,9751,8682,0902,1582,2531,0471,5962,0261,8861,8772,4162,2131,3668359751,7501,1058608483121621,9251,38591552002360111
   > Total Current Liabilities 
111
0
236
0
520
915
1,385
1,925
162
312
848
860
1,105
1,750
975
835
1,366
1,854
2,073
1,551
1,240
1,399
987
766
1,638
1,577
1,544
1,358
1,502
1,705
1,704
1,832
2,033
2,169
903
9032,1692,0331,8321,7041,7051,5021,3581,5441,5771,6387669871,3991,2401,5512,0731,8541,3668359751,7501,1058608483121621,9251,38591552002360111
       Short-term Debt 
0
0
0
0
270
562
950
1,302
1,302
0
0
0
354
681
0
0
0
655
364
107
71
74
76
79
123
128
132
137
142
147
181
186
191
197
202
202197191186181147142137132128123797674711073646550006813540001,3021,3029505622700000
       Short Long Term Debt 
0
0
0
0
0
0
950
1,302
0
0
0
0
423
0
0
0
0
590
298
38
0
0
0
0
0
0
0
0
0
0
28
28
28
28
28
2828282828000000000038298590000042300001,302950000000
       Accounts payable 
25
0
81
0
60
353
228
303
133
228
780
814
463
751
631
553
1,011
647
1,278
1,241
495
874
403
448
807
748
791
834
785
637
614
524
415
419
360
3604194155246146377858347917488074484038744951,2411,2786471,01155363175146381478022813330322835360081025
       Other Current Liabilities 
86
0
155
0
190
0
0
320
30
84
68
46
289
318
343
282
355
0
496
272
745
525
507
239
708
701
1,411
387
575
921
909
1,122
1,870
2,001
340
3402,0011,8701,1229099215753871,411701708239507525745272496035528234331828946688430320001900155086
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
354
1,068
0
0
0
359
343
326
645
628
609
281
615
581
547
510
473
434
366
324
281
237
192
1922372813243664344735105475816152816096286453263433590001,068354000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
354
681
0
0
0
0
0
0
337
337
337
28
0
0
0
0
0
0
0
0
0
0
0
0000000000028337337337000000681354000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000
> Total Stockholder Equity
362
0
250
0
270
-241
-894
-1,380
7,782
7,168
5,275
2,830
1,941
-458
6,248
3,802
1,824
1,403
4,761
2,522
977
3,335
7,169
17,852
14,990
13,156
10,784
9,069
13,334
10,203
7,205
4,499
6,931
5,196
5,659
5,6595,1966,9314,4997,20510,20313,3349,06910,78413,15614,99017,8527,1693,3359772,5224,7611,4031,8243,8026,248-4581,9412,8305,2757,1687,782-1,380-894-24127002500362
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
3
3
4
4
4
4
4
6
6
0
0
1
1
1
11100664444433211111100000000000000
   Retained Earnings Total Equity0000000000-62,928-59,729-57,338-55,088-51,434-48,540-45,217-36,188-32,775-30,440-27,692-25,326-22,568-20,721-17,895-15,601-14,692-13,2600000000
   Accumulated Other Comprehensive Income 
0
0
-208
0
120
-260
-276
-292
-307
-322
-338
-353
-368
-386
-406
-426
-446
-466
-487
-508
-531
-534
-586
-617
0
0
0
0
6
8
6
4
0
0
5
50046860000-617-586-534-531-508-487-466-446-426-406-386-368-353-338-322-307-292-276-2601200-20800
   Capital Surplus 
0
0
0
0
0
0
0
11,790
22,474
22,768
23,171
23,550
24,508
24,868
33,939
34,241
34,598
37,590
49,934
50,982
52,228
58,282
64,494
77,461
77,839
0
0
0
0
0
0
0
0
0
0
000000000077,83977,46164,49458,28252,22850,98249,93437,59034,59834,24133,93924,86824,50823,55023,17122,76822,47411,7900000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
9
0
10,201
0
11,170
11,850
11,901
12,172
22,781
23,090
23,508
23,903
24,876
25,254
34,345
34,667
35,044
38,056
50,464
51,569
52,940
58,954
65,090
78,194
77,914
78,738
79,471
80,613
88,462
88,769
89,068
89,308
94,300
95,666
97,583
97,58395,66694,30089,30889,06888,76988,46280,61379,47178,73877,91478,19465,09058,95452,94051,56950,46438,05635,04434,66734,34525,25424,87623,90323,50823,09022,78112,17211,90111,85011,170010,20109



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-275
Gross Profit-275-275
 
Operating Income (+$)
Gross Profit-275
Operating Expense-10,245
Operating Income-10,521-10,521
 
Operating Expense (+$)
Research Development5,004
Selling General Administrative4,696
Selling And Marketing Expenses821
Operating Expense10,24510,521
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-10,521
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,060-10,981
EBIT - interestExpense = -10,521
-10,060
-10,060
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-10,521-10,060
Earnings Before Interest and Taxes (EBITDA)-10,245
 
After tax Income (+$)
Income Before Tax-10,060
Tax Provision-0
Net Income From Continuing Ops-11,890-10,060
Net Income-10,060
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,521
Total Other Income/Expenses Net4600
 

Technical Analysis of ENDRA Life Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ENDRA Life Sciences Inc. The general trend of ENDRA Life Sciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ENDRA Life Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ENDRA Life Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.3363 < 0.87 < 0.9101.

The bearish price targets are: 0.221.

Tweet this
ENDRA Life Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ENDRA Life Sciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ENDRA Life Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ENDRA Life Sciences Inc. The current macd is -0.15860358.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ENDRA Life Sciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ENDRA Life Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ENDRA Life Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ENDRA Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartENDRA Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ENDRA Life Sciences Inc. The current adx is 51.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ENDRA Life Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ENDRA Life Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ENDRA Life Sciences Inc. The current sar is 0.2818.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ENDRA Life Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ENDRA Life Sciences Inc. The current rsi is 21.98. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
ENDRA Life Sciences Inc Daily Relative Strength Index (RSI) ChartENDRA Life Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ENDRA Life Sciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ENDRA Life Sciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ENDRA Life Sciences Inc Daily Stochastic Oscillator ChartENDRA Life Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ENDRA Life Sciences Inc. The current cci is -87.17026322.

ENDRA Life Sciences Inc Daily Commodity Channel Index (CCI) ChartENDRA Life Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ENDRA Life Sciences Inc. The current cmo is -56.28899719.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ENDRA Life Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartENDRA Life Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ENDRA Life Sciences Inc. The current willr is -87.71428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ENDRA Life Sciences Inc Daily Williams %R ChartENDRA Life Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ENDRA Life Sciences Inc. The current atr is 0.05654188.

ENDRA Life Sciences Inc Daily Average True Range (ATR) ChartENDRA Life Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ENDRA Life Sciences Inc. The current obv is -1,536,684.

ENDRA Life Sciences Inc Daily On-Balance Volume (OBV) ChartENDRA Life Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ENDRA Life Sciences Inc. The current mfi is 36.27.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ENDRA Life Sciences Inc Daily Money Flow Index (MFI) ChartENDRA Life Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ENDRA Life Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

ENDRA Life Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ENDRA Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.985
Ma 20Greater thanMa 500.325
Ma 50Greater thanMa 1000.778
Ma 100Greater thanMa 2001.073
OpenGreater thanClose0.254
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ENDRA Life Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on ENDRA Life Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ENDRA Life Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ENDRA Life Sciences Inc

I send you an email if I find something interesting about ENDRA Life Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ENDRA Life Sciences Inc.

Receive notifications about ENDRA Life Sciences Inc in your mailbox!